Compare Johnson & Johnson (JNJ) vs The Coca-Cola Co K (KO) Price & Performance

Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.

JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.

Coca-Cola (KO) trades at $81.97, up 0.5% today, with a bullish analyst consensus and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $0.86 beating expectations, and robust profitability metrics including a 27.8% net income margin. Technical indicators are mixed, with moving averages bullish but oscillators neutral. Recent news highlights institutional buying and stable demand trends, though regional divergences exist.

The outlook remains positive with a consensus price target of $90.67, offering ~11% upside. Risks include macroeconomic headwinds and competitive pressures, but the company's dividend history and strong cash flow support long-term stability. Earnings growth and institutional confidence are key catalysts for further appreciation.